Targeting Ferroptosis in Neurological Diseases
This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Special Issue Information
Dear Colleagues,
Novel research continues to implicate aberrant iron homeostasis in neurological disease. This dysregulation can lead to oxidative stress and ultimately ferroptosis, a form of cell death caused by lipid peroxidation. Ferroptosis is a rich target for biomedicines as its mechanisms continue to be discovered. These biomedicines could be especially beneficial in neurodegenerative diseases, which currently lack effective treatments. Treatments for neurodegenerative disease often target inflammation and excitotoxicity, which evidence suggests mediate ferroptosis. Despite a clear link to ferroptosis, many studies of drugs for neurodegeneration do not explore markers of ferroptsis such as glutathione peroxidase 4 (GPX4) and lipid peroxidation products. Therefore, this Special Issue seeks articles on therapeutics targeting iron homeostasis and ferroptosis for neurological disease, with an emphasis on neurodegeneration. Primary research articles and literature reviews that stimulate discussion on ferroptosis in neurological disease are invited. Pathologies of interest include primary neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, as well as mechanisms of neurodegeneration secondary to acute brain injuries, such as traumatic brain injury, ischemic stroke, and subarachnoid hemorrhage.
Dr. Brandon Lucke-Wold
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- iron
- neurodegeneration
- ferroptosis
- glutathione peroxidase 4
- lipid peroxidation
- Alzheimer’s disease
- Parkinson’s disease
- traumatic brain injury
- stroke
- subarachnoid hemorrhage
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

